Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online August 17, 2010.
Article Versions
- Earlier version (July 6, 2010 - 08:02).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Sarah L. Pitkin,
- Janet. J. Maguire,
- Tom I. Bonner, and
- Anthony P. Davenport
- Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (S.L.P., J.J.M., A.P.D.); and Section on Functional Neuroscience, National Institute of Mental Health, Bethesda, Maryland (T.I.B.)
- Address correspondence to: Dr. Anthony Davenport, NC-IUPHAR Emerging Pharmacology Group, Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. E-mail: apd10{at}medschl.cam.ac.uk
Statistics from Altmetric.com
Article usage
In this issue
International Union of Basic and Clinical Pharmacology. LXXIV. Apelin Receptor Nomenclature, Distribution, Pharmacology, and Function
Jump to section
- Article
- Abstract
- I. Introduction
- II. The Apelin Receptor: Recommendations for Nomenclature
- III. Receptor Structure
- IV. Endogenous Agonists
- V. Receptor Distribution
- VI. Apelin Peptide Distribution
- VII. Synthetic Agonists
- VIII. Antagonists
- IX. Radiolabeled Ligands
- X. Physiological Roles
- XI. Pathophysiological Roles
- XII. Single-Nucleotide Polymorphisms
- XIII. Knockout Mouse Models
- XIV. Conclusion
- Acknowledgments.
- Footnotes
- References
- Figures & Data
- Info & Metrics
- eLetters